(1)
sukahar, A. A. RISK OF HBV REACTIVATION DURING THERAPIES FOR HCC: A SYSTEMATIC REVIEW. JARMHS 2023, 9 (10), 111-116. https://doi.org/10.53555/t0qwb657.